Baltimore Adopts Evolve™ Rodent Birth Control for Integrated Pest Management Targeting Rodent Overpopulation

Identifies Population Control as a Humane, Effective Solution for Winning the War Against Rats SenesTech, Inc. (NASDAQ: SNES), a leader in innovative pest control solutions, is pleased to announce that the City of Baltimore has begun integrating Evolve™, SenesTech's cutting-edge rodent birth control product, into the city's rodent management programs. This marks a pivotal step […]

Dean’s Dip Unveils Five New, On-Trend, Flavorful Dips, Perfect for Any Snacking Occasion

Leading dairy dip brand introduces Creamy Dill and Jalapeño Popper classic dips and new Cantina Dairy Dip sub-line featuring three varieties Dean's Dip, the trusted dairy dip brand best known for its original and irresistible French Onion Dip, is launching five new flavors to give foodies and snackers something exciting and delicious to enjoy. In

Pura x Pantone Partner for the Pantone Color of the Year 2025, a First in Home Fragrance Category

The Smart Home Fragrance Brand to Launch Limited Edition Diffuser + Set of Two Fragrances Pura, the smart home fragrance company that marries premium fragrance with innovative technology, is announced today as one of Pantone's official brand partnersincelebrationofPantone's selectionofPANTONE 17-1230 Mocha Mousse as the Pantone ColoroftheYear 2025. As Pantone's first home fragrance brand partner, Pura

JND eDiscovery Names Jonathan Moody Vice President – Sales

Jonathan combines first-hand technical prowess with a dedication to relationship building. JND Legal Administration, the U.S. leader in legal management and administration services, announces the promotion of Jonathan Moody to Vice President of eDiscovery Sales. https://mma.prnewswire.com/media/2599100/Jonathan_Moody.jpg Jonathan's experience encompasses more than a decade of guiding law firms and corporations through complex, data-intensive matters, with firms

Arrive Health, in partnership with AWS and a leading Integrated Delivery Network, Launches Innovative Generative AI-Powered Solution to Accelerate Medication Access

Arrive Health, a leader for the past decade in real-time prescription benefits, today announced the expansion of their medication access solutions with the launch of arrive ACCELERATE. arrive ACCELERATE harnesses the power of generative AI to streamline the prior authorization process, enabling choice to drive faster time to therapy and improved patient outcomes. Developed in

CFD Companies Focuses on Building Community with Financial Professionals

CFD Companies, home to a fully independent Broker/Dealer and RIA, announced key community building initiatives for 2025. Though the firm has experienced significant growth, it remains committed to fostering a family-like community that is the foundation for delivering exceptional service. Key initiatives recently announced were: — 25th Anniversary Presidential Adviser Trip:CFD will celebrate the 25th

Rogers and TIFF Sign Multi-Year Deal

(TSX:RCI-A),(TSX:RCI-B),(NYSE:RCI), Will bring Canadians exclusive content from the FestivalWill create VIP red carpet experience for Rogers customers TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — Toronto International Film Festival and Rogers are pleased to announce a three-year agreement that will see Rogers return as the official Presenting Partner of the Festival and the People's Choice Award

Uniti Announces New Long-Haul Fiber Contract Award with Large Hyperscaler

(NASDAQ:UNIT), LITTLE ROCK, Ark., Jan. 21, 2025 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) is pleased to announce a new 20-year long-haul fiber and conduit contract award from an existing strategic hyperscale customer that will connect Montgomery, AL, one of Uniti's existing 30+ enterprise markets, to Cuba, AL. As part of this contract

Glucotrack Announces ISO 13485:2016 Certification

(NASDAQ:GCTK), RUTHERFORD, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it has received ISO 13485:2016 certification from the British Standards Institute (BSI). “This ISO certification is a

Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population

(NASDAQ:MYNZ), eAArly DETECT 2 feasibility study designed to validate earlier results on advanced adenomas over a large population of average risk patients Multi-center study expected to complete enrollment in the second half and reporting in the Fourth Quarter of 2025 BERKELEY, Calif. and MAINZ, Germany, Jan. 21, 2025 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ)

Scroll to Top